Chief Access Officer and Vice President, Global Regulatory Affairs at MedDay Pharmaceuticals
Philippe Motté is leads the global functions governing the access of drugs at MedDay Pharmaceuticals, encompassing Quality, Safety, Regulatory Affairs and Market Access. Philippe has more than 20 years expertise in regulatory affairs and market access. He is a pharmacist, and he holds a PhD in biochemistry and an MBA from ESCP-EAP. Philippe started in academics in France and as a post-doc fellow at Harvard Medical School (Boston, USA) where he developed monoclonal antibody-based cancer diagnostic and therapeutic tools. Philippe began his career in the industry in France at Pasteur-Mérieux (now the vaccine branch of Sanofi) in the biotechnology and vaccine field. Joining SmithKline Beecham (now GSK), he registered the first hepatitis A vaccine and subsequent products, and then took responsibility for marketing an antibiotic franchise. He further managed market access of major innovative drugs at Roche, and at Ipsen as the Head for regulatory affairs and market access. Enlarging his scope, he took international responsibilities at Ipsen as the VP Global Regulatory Affairs where he strongly contributed to the international expansion of the company. Philippe then joined AbbVie at its inception as Head of Western Europe Regulatory Affairs, where he obtained a strong track record in biologics, immunology, hepatitis C and oncology. Prior to joining MedDay in 2018, he was the VP Regulatory Affairs International at AbbVie, where he rolled out the portfolio in Latin America, Europe, EEMEA and Asia-Pacific. In all those positions, Philippe has gained a robust expertise in designing regulatory strategies and gaining access to market in Europe, US and International markets. Philippe is also Visiting Professor at the University of Paris-Saclay where he teaches Regulatory Affairs at the School of Pharmacy. Philippe is a member of the French national academy of Pharmaceutical Sciences.